Dr. Greg Goldmacher from @Merck joins #TheHealthPulse podcast to discuss AI’s ability to automate advanced image measurements, improve diagnosis and support clinical development. https://t.co/z312OlpjmX
🔥 Merck MSD, listen in as colleague, Dr. Greg Goldmacher, AVP for Clinical Research and Head of Clinical Imaging and Pathology at Merck, weighs in on AI’s potential to enable diagnosis and opportunistic screening.
#TheHealthPulse podcast #innovation
https://t.co/mL56mNTp93
⭐SAS is the only Leader in all 3 analyst reports!⭐
SAS Viya provides operationalization of models and decisions, in real time, on one platform. 👇
https://t.co/BQfsAFsmc4
#innovation#technology#analystreport
💡Merck MSD, Read this blog to learn more about the benefits of a developer workbench for efficient, collaborative, and secure model development. https://t.co/veL9VVtboy
❓ Need Trustworthy GenAI? ✔️SAS broadens GenAI offerings with synthetic data generator and sector specific GenAI assistants. https://t.co/Swvz61AODT #GenerativeAI#SASViya#Innovation
Need a fast, multilingual environment to build AI / ML models?
🚀SAS Viya Workbench: A self-service, on-demand compute environment for developers/modelers to accelerate model development & deployment. A scalable, secure environment with trusted outputs. https://t.co/WpNzzrUEGj
Did you miss this?! SAS 🚀launches lightweight SAS models, among other new products, that allow companies to address a broader range of use cases and give customers considerably more choice in the solutions available to them. Read more @channelbuzzca :
https://t.co/NktDygXZHR
🔥Merck MSD, looking to leverage #GenAI in life sciences. Don't miss our upcoming webinar on May 7th! Join industry thought leaders and learn how GenAI can address challenges and accelerate breakthroughs in drug development. #innovation
Register now: https://t.co/4Q2Www61RL
🔥Merck MSD, Don't Miss This! Life Sciences expert Matt Becker will unveil our newest solution, SAS Clinical Acceleration Repository. Super demo session April 17th. Attending Innovate, add this session to your schedule!
Register now! https://t.co/w5qOg5ld2b #innovation#SASViya
Improve speed! AstraZeneca's Simon Holdsworth will reveal how AZ accelerate new drug discovery and digital clinical trials! #SASInnovate https://t.co/KkiR55BPgJ
Learn about a global organization’s innovative goals for redefining clinical data flows. #innovation#drugdiscovery
Don't miss Patrick Loerch, Sr VP ClInical Data Science at Gilead, present on advances in AI, new trial designs, open source integration, and real world data.
Join peers and partners at SAS Innovate!
https://t.co/pfED5rnkRJ
Merck MSD, are you curious to know how analytics is revolutionizing rare disease diagnosis, treatment, and patient management?https://t.co/1H0vw07pqx #innovation#technology#life sciences
Imagine working effortlessly in every computing environment – SAS, Python, R, other open source languages. New reality arriving with SAS Viya Workbench, a highly scalable, cloud development environment.
Free Webinar March 5, 11 am ET
Register: https://t.co/5hfvbA4gkf
#innovation
Put your chips all in! Come find out why SAS Viya is the most productive data and AI platform! #SASInnovate, April 16-19, Las Vegas ARIA. Register now!
Get inspired, get informed, and get going on your data challenges!
https://t.co/SdXq0ViF7C #GenAI#AI#SASInnovate!
Health care and life sciences is changing – and the shifting landscape of technology is poised to enable a healthier future for all. What does this mean in 2024 and beyond? On Feb. 20 at 10am ET dive into the top trends globally. https://t.co/dDlOlTEU2D
Come learn about the new Distributed Open Source Code (DOSC) node that was recently made available in the SAS Visual Forecasting. Join this #SASwebinar LIVE January 30 at 10 am ET. Register: https://t.co/lkRBrkmVMe
Merck Animal Health, you may have missed news... In a scientific first, U.K. researchers used gene editing technology to create poultry that's partially resistant to bird flu infection. SAS epidemiologist Meg Schaeffer shares her thoughts with USA Today.
https://t.co/etcP4N3FPb
AstraZeneca has appointed SAS to provide cloud-based software solutions with an aim to boost efficiency and automation in the delivery of statistical analyses for clinical and post-approval submissions to regulatory authorities.
https://t.co/MLhVAmg5BA
Can we integrate Python models into the SAS Viya Platform? Of course! Join Solutions Advisor Cameron Taylor as he walks through how SAS Viya embraces open source models. https://t.co/gZyOQw7tyJ
How do we include open source technologies in drug development... without posing risks to patients, patents and to the teams developing lifesaving products?
Find out more.. https://t.co/iGG1wCZhAW via @BioPharmaDive